CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Option exercise President and CEO acquired 20,000 shares (option exercise)
- 4 Option exercise President and CEO acquired 11,298 shares (option exercise)
- 4 Open-market sale 10% owner sold 59,950 shares at $20.71 ($1,241,325)
- 8-K Event Other events
- 4 Open-market sale 10% owner sold 39,518 shares at an average $20.61 ($814,398)
- 4 Open-market sale 10% owner sold 20,365 shares at an average $20.55 ($418,508)
- 4/A Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 13,155 shares at an average $20.66 ($271,768)
- 4 Open-market sale Chief Scientific Officer sold 3,500 shares at $21.29 ($74,500)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Grant or award Chief Medical Officer acquired 6,500 shares (grant or award)
- 4 Grant or award President and CEO acquired 25,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 6,000 shares (grant or award)
- 4 Open-market sale Chief Scientific Officer sold 875 shares at $20.00 ($17,500)
- 8-K Event Executive or director change
Page 29 of 36 · 707 filings